REDWOOD CITY, Calif., Oct. 07, 2026 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (“J

On September 23, 2026, Herb Cross submitted his resignation, effective as of October 9, 2026, as Chi

Lisa Pitt, Pharm.D., M.S.J. appointed Senior Vice President, Regulatory Affairs Shiguang Liu, M.D.

REDWOOD CITY, Calif., Sept. 09, 2026 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (“

Gainers Can Fite Biopharma (AMEX:CANF) shares moved upwards by 20.4% to $3.96 during Wednesday'

Dell Technologies (DELL) stock jumps in pre-market trading after reporting better-than-expected Q2 r

Gainers AIxCrypto Hldgs (NASDAQ:AIXC) stock increased by 132.0% to $1.65 during Tuesday's regul

Jasper Therapeutics (NASDAQ:JSPR) reported quarterly losses of $(0.10) per share which beat the anal

Acquisition of Kira Pharmaceuticals closed in July creating a combined company with a robust portfol

Piper Sandler analyst Biren Amin initiates coverage on Jasper Therapeutics (NASDAQ:JSPR) with a O

Gainers Neuronetics (NASDAQ:STIM) shares moved upwards by 34.1% to $2.91 during Tuesday's regul

Deal Dispatch features companies for sale or bought — also off the block — and what bankruptcies are

Jasper Therapeutics Inc. (NASDAQ:JSPR) on Thursday said it completed its all-stock acquisition of Ki

Jasper Therapeutics (JSPR) acquires Kira Pharma & raises $132M, extending its cash runway into 2

Gainers Jasper Therapeutics (NASDAQ:JSPR) stock moved upwards by 19.2% to $0.92 during Friday's

Gainers Anixa Biosciences (NASDAQ:ANIX) shares rose 10.0% to $3.65 during Friday's pre-market s

Callan JMB Inc (CJMB) shares jumped 63.8% in pre-market trading after announcing a strategic partner

Jasper Therapeutics, Inc. (NASDAQ:JSPR) ("Jasper" or the "Company"), today announced

Combined company positioned to advance portfolio of biologic agents designed to improve outcomes in

Gainers Exicure (NASDAQ:XCUR) stock rose 38.4% to $2.38 during Tuesday's after-market session.

Gainers EUDA Health Holdings (NASDAQ:EUDA) shares rose 22.3% to $15.2 during Friday's regular s

Gainers Vicore Pharma Holding (NASDAQ:VCRE) stock rose 149.8% to $42.47 during Monday's after-m

https://www.sec.gov/ix?doc=/Archives/edgar/data/0001788028/000121390026066782/ea0294010-8k_jasper.ht

Major M&A deals this week include: New Mountail Capital buys Asset Living, SalesForce acquires C

Jasper Therapeutics (JSPR) appears to have found support after losing some value lately, as indicate

REDWOOD CITY, Calif., June 01, 2026 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Ja

RBC Capital analyst Leonid Timashev maintains Jasper Therapeutics (NASDAQ:JSPR) with a Sector Per

REDWOOD CITY, Calif., May 14, 2026 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jas

Evercore ISI Group analyst Gavin Clark-Gartner maintains Jasper Therapeutics (NASDAQ:JSPR) with a

Jasper Therapeutics (NASDAQ:JSPR) reported quarterly losses of $(0.32) per share which beat the anal

REDWOOD CITY, Calif., March 30, 2026 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (J

Pre-Market Stock Futures: Futures are trading higher after President Trump signalled that talks with

REDWOOD CITY, Calif., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Ja

Jasper Therapeutics, Inc. (JSPR) Discusses Updated Data from BEACON and Open-Label Extension Studies

67% of additional patients (n=6) enrolled in the BEACON study achieved a complete response at 12 wee

67% of additional patients (n=6) enrolled in the BEACON study achieved a complete response at 12 wee

Thomas Wiggans appointed Executive Chairperson  Jasper to host an investor webinar on January 8 th a

Jasper Therapeutics, Inc. (NASDAQ: JSPR - Get Free Report)'s share price traded down 7.3% on Monday.

Jasper Therapeutics, Inc. (JSPR) Discusses Investigation Into BEACON Study Anomalies and Preliminary

Jasper Therapeutics released positive data from a study of subcutaneous briquilimab for allergic ast

MDB: 24% | MongoDB shares are trading higher after the company reported better-than-expected Q3 fina

Reductions in airway hyperresponsiveness and suppressed eosinophilic response at both 6 weeks and 12

REDWOOD CITY, Calif., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Ja